Lantern Pharma, Inc. (LTRN)
NASDAQ:LTRN
US Market
Holding LTRN?
Track your performance easily

Lantern Pharma (LTRN) Financial Statements

236 Followers

Lantern Pharma Financial Overview

Lantern Pharma's market cap is currently ―. The company's EPS TTM is $-1.646; its P/E ratio is -1.99; Lantern Pharma is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -4.96M$ 6.02M$ -4.88M$ -3.16M$ -4.75M
EBITDA$ -4.96M$ 6.03M$ -4.87M$ -3.16M$ -4.74M
Net Income Common Stockholders$ -4.96M$ -5.44M$ -4.19M$ -3.16M$ -4.75M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 33.26M$ 38.36M$ 41.30M$ 44.93M$ 48.49M
Total Assets$ 35.59M$ 39.73M$ 43.65M$ 47.77M$ 51.43M
Total Debt$ 218.70K$ 193.58K$ 234.47K$ 274.53K$ 313.86K
Net Debt$ -33.04M$ -38.16M$ -41.07M$ -44.65M$ -48.18M
Total Liabilities$ 4.66M$ 3.97M$ 2.74M$ 2.36M$ 3.17M
Stockholders Equity$ 30.93M$ 35.77M$ 40.91M$ 45.41M$ 48.26M
Cash Flow-
Free Cash Flow$ -5.19M$ -3.07M$ -3.39M$ -3.62M$ -3.63M
Operating Cash Flow$ -5.19M$ -3.07M$ -3.39M$ -3.61M$ -3.63M
Investing Cash Flow$ -202.06K$ -556.17K$ 256.18K$ 231.73K$ -457.24K
Financing Cash Flow-$ 54.72K$ -500.00K--
Currency in USD

Lantern Pharma Earnings and Revenue History

Lantern Pharma Debt to Assets

Lantern Pharma Cash Flow

Lantern Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis